|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Safety,tolerability,pharmacokinetics,and pharmacodynamics of irbesartan after single and multiple doese in healthy male subjects显示文摘 | Marino MR Langenbacher KM Ford NF | 1997 | Clin Pharmacol Ther1997，61，： | 1 |
| 2 | Safety,tolerability,pharmacokinetics and pharmacodynamics of irbesartan after single and multiple dose in healthy male subjects显示文摘 | Marino MR Langenbacher KM Ford NF | 1997 | Clin Pharmacol Ther1997，61，： | 1 |
| 3 | Safety,toler-abilillty,pharamacoklnetics and pharmacodynamics of irbesartan after single and multiple dose in healthy male subjects 显示文摘 | Marino MB Langenbacher KM Ford NF | 1997 | Clin pharmacol Ther1997，61，： | 1 |
| 4 | Clopidogrel,CYP2C19 and a Black Box显示文摘 | Ford NF Taubert D | 2013 | J Clin Pharmacol2013，53，： | 1 |
| 5 | Fosinopril monotherapy:relationship between blood pressurs reduction and time of administration显示文摘 | Ford NF Fulmor IE Nichola PS | 1993 | Clin Cardiol1993，16，2： | 1 |
| 6 | Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects 显示文摘 | Marino MR Langenbocher K Ford NF | 1998 | J Clin Pharmacol1998，38，3： | 1 |
| 7 | Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects 显示文摘 | Marino MR Langenbacher K Ford NF | 1998 | Clin Pharmacol1998，38，2： | 1 |
| 8 | Pharmacokinetics and Pharmacodynamics of irbesartan in Healthy subjects显示文摘 | Marino MR Langenbocher K Ford NF | 1998 | J Clin Pharmacol1998，38，： | 1 |
| 9 | Pharmacokinetics and Pharmacodynamics of irbesartan inHealthy subjects 显示文摘 | Marino MR LangenbocherK Ford NF | 1998 | J Clin Pharmacol1998，38，3： | 1 |
| 10 | Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects显示文摘 | Marino MR Langenbacher K Ford NF | 1998 | J Clin Pharmacol1998，38，3： | 1 |
| 11 | Pharmacodynamics and pharmacokinetics of irbesartan in patients with moderate hypertension显示文摘 | Marino MR Langenbacher KM Ford NF | 1999 | J Cardiovasc Pharmacol Ther1999，4，2： | 1 |
| 12 | Safety, tolerar bility, pharmacokinetics and pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects显示文摘 | Marino MR Langenbacher KM Ford NF | 1997 | Clin Pharmacol Ther1997，61，： | 1 |
| 13 | Pharmacokinetics and pharmaeodynamics of Irbesartan in health subjects显示文摘 | Marino Mr Langenvacher K Ford NF | 1998 | J Clin Phar- maeol1998，38，： | 1 |
| 14 | Safety, tolerability, pharmacodynamics of irbesartan after single and multiple doses in healthy male subjects 显示文摘 | Marino MR Langenbacher KM Ford NF | 1997 | Clin Pharmacol Ther1997，61，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员